WP
ALT icon

WealthPLAN Partners’s Altimmune ALT Stock Holding History

WealthPLAN Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,204
Closed -$73.6K – 246
2024
Q4 		$73.6K Hold
10,204
– – 0.01% 239
2024
Q3 		$62.7K Hold
10,204
– – 0.01% 254
2024
Q2 		$67.9K Hold
10,204
– – 0.01% 293
2024
Q1 		$104K Sell
10,204
-866
-8% -$8.81K 0.01% 299
2023
Q4 		$125K Sell
11,070
-861
-7% -$3.6K 0.01% 313
2023
Q3 		$31K Hold
11,931
– – ﹤0.01% 311
2023
Q2 		$42.1K Hold
11,931
– – 0.01% 542
2023
Q1 		$50.3K Hold
11,931
– – 0.01% 556
2022
Q4 		$148K Buy
+11,931
New +$134K 0.01% 378

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WealthPLAN Partners's ALT Position: Q1 2025 in Review

WealthPLAN Partners sold out of Altimmune (ALT) in Q1 2025, closing a stake of 10,204 shares — an estimated $73.6K sold.

WealthPLAN Partners first reported a position in ALT in Q4 2022 and held it in 9 quarters. The position peaked at $148K in Q4 2022. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • WealthPLAN Partners reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • WealthPLAN Partners sold 10,204 Altimmune shares in Q1 2025, an estimated $73.6K.
  • WealthPLAN Partners first reported a position in Altimmune in Q4 2022 and held it in 9 quarters.
  • WealthPLAN Partners's Altimmune position peaked at $148K in Q4 2022.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on WealthPLAN Partners's 13F filing for Q1 2025, filed 12 May 2025.